Gerri Baer is a Medical Officer and Team Leader for Neonatology in the Office of Pediatric Therapeutics at FDA.
She completed pediatric residency and chief residency at Mount Sinai Medical Center in New York City. She worked as a NICU hospitalist before starting her neonatology fellowship training at the Children’s Hospital of Philadelphia. She is board-certified in pediatrics and neonatal-perinatal medicine.
Prior to joining the FDA in September of 2015, she worked for 8 years as an attending neonatologist in a large level III NICU in Silver Spring, Maryland. She was a partner in the practice and site lead for the Vermont-Oxford Very Low Birth Weight Neonatal Database.
At FDA, she has established the Neonatal-Perinatal Medicine consultation service and is involved with neonatal product development across the Centers. She also serves on the coordinating committee of the International Neonatal Consortium (INC) and represents the FDA on INC working groups.